Exploring The Booming Stem Cell Therapy Market: Trends And Opportunities

By Author: Snehal S
Total Articles: 396
Comment this article

Key drivers of the stem cell therapy market include increase in stem cell research funding, expanding number of clinical trials related to stem cell therapies, and growing number of GMP-certified cell therapy production facilities. However, high costs associated with the development of stem cell therapy along with the ethical concerns related to embryonic stem cells are likely to hamper the market growth to a certain extent.

Stem Cell Therapy Market is projected to reach USD 558 million by 2027 from USD 257 million in 2022, at a CAGR of 16.8% during the forecast period, according to a new report by MarketsandMarkets™.

Browse in-depth TOC on "Stem Cell Therapy Market"
155 – Tables
43 – Figures
166 – Pages

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48

KEY MARKET DYNAMICS
1 DRIVERS
1 Availability of funding for stem cell research
2 Increasing GMP certification approvals for cell therapy production facilities
3 Increasing clinical trials for ...
... stem cell-based therapies
2 RESTRAINTS
1 Ethical concerns related to embryonic stem cells
2 High cost of cell-based research
3 OPPORTUNITIES
1 Emergence of iPSCs as an alternative to ESCs
2 Growing demand for cell & gene therapies
4 CHALLENGES
1 Technical limitations associated with manufacturing processes

Market Segmentation

The global stem cell therapy market is segmented into adipose tissue-derived MSCs (mesenchymal stem cells), bone marrow-derived MSCs, placenta/umbilical cord-derived MSCs, and other cell sources.
Based on therapeutic application, the global stem cell therapy market is segmented into musculoskeletal disorders, wounds & injuries, cardiovascular diseases, surgeries, inflammatory & autoimmune diseases, neurological disorders, and other therapeutic applications.

Request For 10% Customization:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=48
Regional Analysis
The Asia Pacific region is estimated to grow at the highest CAGR in the stem cell therapy market during the forecast period. Japan and South Korea are the key revenue contributors of the Asia Pacific stem cell therapy market. Favorable government support for product approvals and the presence of major players in these countries are anticipated to drive the regional market growth.